Memel Biotech has launched a fully integrated advanced therapy development and manufacturing service from its facility located at the Baltic seaport of Klaipeda, Lithuania.   Memel will target partnerships with both emerging and established biotech companies looking to enter the advanced therapy space. Operating from a new GMP facility, Memel will offer a seamless discovery-to-delivery service for all three classes of advanced therapies – cell, gene, and tissue engineered.   Memel’s manufact...